Camping season is in full swing, which means it's time to gear up and get outside. Thankfully, gear deals are happening ...
The new panel marks the fourth FDA clearance of a QIAstat-Dx panel in ... with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years ...
QIAstat-Dx Meningitis/Encephalitis Panel cleared in the U.S. for use in clinical settings to help diagnose central nervous system infections // Fourth FDA clearance marks milestone in 2024 in ...
QIAGEN N.V. QGEN recently achieved FDA clearance for its QIAstat-Dx Respiratory Panel Mini test for clinical use. This is the second QIAstat-Dx respiratory panel to receive U.S. regulatory nod ...
This new panel marks the fourth FDA clearance of a QIAstat-Dx panel in 2024, and comes after the recent FDA clearances for other tests: QIAstat-Dx Gastrointestinal Panel 2 QIAstat-Dx Respiratory ...
It is the third test to receive FDA clearance for use with QIAstat-Dx systems in 2024. The QIAstat-Dx Respiratory Panel Mini is designed to support clinical decision making in diagnosing upper ...
It is the third test to receive FDA clearance for use with QIAstat-Dx systems in 2024. The QIAstat-Dx Respiratory Panel Mini is designed to support clinical decision making in diagnosing upper ...
“This marks the fourth FDA clearance for a QIAstat-Dx test in 2024, and a signal of our commitment to expanding our test menu in the U.S. as well as around the world.” The QIAstat-Dx ...